| Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges MDA Paskeh, F Ghadyani, M Hashemi, A Abbaspour, A Zabolian, ... Pharmacological research 187, 106553, 2023 | 56 | 2023 |
| Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis A Taheriazam, GGY Abad, S Hajimazdarany, MH Imani, S Ziaolhagh, ... Journal of Controlled Release 354, 503-522, 2023 | 41 | 2023 |
| Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions M Hashemi, S Etemad, S Rezaei, S Ziaolhagh, R Rajabi, P Rahmanian, ... Biomedicine & Pharmacotherapy 158, 114204, 2023 | 40 | 2023 |
| Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies M Hashemi, MA Zandieh, Y Talebi, P Rahmanian, SS Shafiee, MM Nejad, ... Biomedicine & Pharmacotherapy 160, 114392, 2023 | 31 | 2023 |
| Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches M Hashemi, N Nadafzadeh, MH Imani, R Rajabi, S Ziaolhagh, ... Cell Communication and Signaling 21 (1), 32, 2023 | 19 | 2023 |
| Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectives MA Zandieh, MH Farahani, R Rajabi, ST Avval, K Karimi, P Rahmanian, ... Pharmacological Research 187, 106582, 2023 | 11 | 2023 |
| Epigenetic regulation of temozolomide resistance in human cancers with an emphasis on brain tumors: Function of non-coding RNAs A Rezaee, PM Tehrany, FJ Tirabadi, N Sanadgol, AS Karimi, A Ajdari, ... Biomedicine & Pharmacotherapy 165, 115187, 2023 | 5 | 2023 |
| Nanostructures for site-specific delivery of oxaliplatin cancer therapy: Versatile nanoplatforms in synergistic cancer therapy M Bagheri, MA Zandieh, M Daryab, SS Samaei, S Gholami, P Rahmanian, ... Translational Oncology 39, 101838, 2024 | 3 | 2024 |
| PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation S Rezaei, N Nikpanjeh, A Rezaee, S Gholami, R Hashemipour, N Biavarz, ... European Journal of Pharmacology, 175909, 2023 | 2 | 2023 |
| miRNAs as short non-coding RNAs in regulating doxorubicin resistance S Mirzaei, MDA Paskeh, FA Moghadam, M Entezari, ZK Koohpar, ... Journal of Cell Communication and Signaling 17 (4), 1181-1202, 2023 | 1 | 2023 |
| Non-coding Rna Transcripts In Cancer Therapy: Pre-clinical And Clinical Implications G Sethi, M Ashrafizadeh World Scientific, 2023 | 1 | 2023 |
| Exosomal long non-coding RNAs (lncRNAs) in cancer progression and diagnosis MA Zandieh, NR Naeini, R Rajabi, S Salimimoghadam, K Hushmandi, ... NON-CODING RNA TRANSCRIPTS IN CANCER THERAPY: Pre-clinical and Clinical …, 2023 | 1 | 2023 |
| Autophagy in hepatocellular carcinoma: mechanisms and potential treatment targets M Hashemi, N Nadafzadeh, MH Imani, R Rajabi, S Ziaolhagh, ... | | 2023 |
Mohamad Arad ZandiehFaculty of Veterinary Medicine, Tehran University在 ut.ac.ir 的电子邮件经过验证
Mohamad Arad ZandiehFaculty of Veterinary Medicine, Tehran University在 ut.ac.ir 的电子邮件经过验证